Novel Copper Peptide Hydrogel Scaffolds Significantly Improve Diabetic Wound Healing

Diabetic wounds are a severe complication of diabetes, characterized by chronic inflammation, impaired angiogenesis (new blood vessel formation), and slow healing, often leading to infections and amputations. Current treatments often lack the ability to effectively accelerate tissue regeneration and restore normal skin function. There is a critical need for advanced biomaterials that can actively promote healing in this challenging environment, and this study addresses the lack of effective biomimetic scaffolds incorporating pro-healing peptides for diabetic wound repair.

The copper peptide-functionalized hydrogel significantly accelerated wound closure compared to controls. Wounds treated with the copper peptide hydrogel achieved 92% closure by day 14, a substantial improvement over the 48% closure in the untreated group and 65% closure in the RADA16-only group (p<0.001). Histological analysis revealed a 2.7-fold increase in microvessel density and a 3.1-fold increase in collagen deposition in the treated wounds compared to untreated controls (p<0.01). Furthermore, the hydrogel treatment led to a 45% reduction in inflammatory cytokine levels (e.g., TNF-α, IL-6) within the wound bed by day 7 (p<0.05), indicating a more favorable healing environment. These findings demonstrate the potent regenerative capabilities of the functionalized scaffold.